Pfizer CEO Supports Trump Calls for Lower Pricing, Manufacturing Jobs -- Update
January 31 2017 - 12:17PM
Dow Jones News
By Jonathan D. Rockoff
Pfizer Inc. (PFE) Chief Executive Ian Read on Tuesday voiced
support for President Donald Trump's calls to add drug
manufacturing in the U.S., saying a corporate-tax overhaul would
pave the way for Pfizer to add U.S. manufacturing jobs.
"We are driven by the tax code to manufacture outside the United
States," Mr. Read said during Pfizer's earnings conference call.
Changes to the tax code would "encourage us" to manufacture more in
the U.S., he added.
Mr. Read also expressed support for helping patients better
afford prescription drugs--a topic Mr. Trump broached with
pharmaceutical chief executives at the White House on Tuesday. But
Mr. Read blamed the costs that patients are paying on regulatory
delays for generic-drug approvals and out-of-pocket costs imposed
by health plans.
"There's lots of ways we can work with the administration to
ensure patients have affordable drugs or more affordable drugs,"
Mr. Read said during the earnings call. He said he couldn't attend
the White House meeting because of Tuesday's earnings report.
Mr. Read said he was looking forward to learning Mr. Trump's
nominee for the Food and Drug Administration. Mr. Read said the
agency could help introduce more price competition for drugs by
approving lower-priced generic medicines faster.
The Pfizer CEO also recommended rules changes that the drug
industry has been pushing for. Specifically, Mr. Read asked for
amendments that would allow drug companies to negotiate
reimbursement for their drugs based on how much they benefit
patients, rather than the drugs' use.
Mr. Read also urged closing the gap between the out-of-pocket
costs patients face for hospitalization as compared with drug
prescriptions. Mr. Read said patients pay about 15% of their drug
costs out of pocket, but only 3% of hospital costs.
Pfizer, based in New York, is the largest pharmaceutical company
based in the U.S. by sales of prescription drugs.
Mr. Read also agreed with Mr. Trump's allegation that foreign
countries are "freeloading" on the U.S. by paying lower prices for
drugs. "As far as free riding on American pharmaceuticals, I
totally agree with him and hope he does something on this," Mr.
Read said.
Write to Jonathan D. Rockoff at jonathan.rockoff@wsj.com
(END) Dow Jones Newswires
January 31, 2017 12:02 ET (17:02 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024